Leadership Overview
Daewoong Pharmaceutical has 4 executives leading key functions including strategy, operations, and market expansion.
Driven by a commitment to global health, Daewoong Pharmaceutical develops, manufactures, and commercializes pharmaceuticals, providing total healthcare solutions worldwide through robust R&D and qualified manufacturing.
Driven by a commitment to global health, Daewoong Pharmaceutical develops, manufactures, and commercializes pharmaceuticals, providing total healthcare solutions worldwide through robust R&D and qualified manufacturing.
Leadership Roles at Daewoong Pharmaceutical
Minsuk Lee - Chief Executive Officer
Minsuk Lee, the Chief Executive Officer at Daewoong Pharmaceutical, directs the company's overarching strategy and global vision. Overseeing all major business units, Lee ensures alignment with the mission to become a leading global healthcare provider. This leadership involves driving innovation in pharmaceutical development and expanding market reach across Asia and the United States. By leveraging Daewoong's cGMP-qualified manufacturing facilities, Lee guarantees the production of high-quality pharmaceuticals for both domestic and international customers. The Chief Executive Officer's role is critical in navigating complex regulatory landscapes and fostering strategic partnerships to enhance the company's competitive position. Minsuk Lee's executive decisions shape the future direction of Daewoong Pharmaceutical, focusing on sustainable growth and impactful healthcare solutions.
Hyun Howoong - Chief Executive Officer & President
Hyun Howoong, the Chief Executive Officer & President at Daewoong Pharmaceutical, executes the company's strategic initiatives and oversees daily operations. This dual role demands a comprehensive understanding of both long-term planning and immediate operational needs, ensuring Daewoong Pharmaceutical delivers total healthcare solutions globally. Howoong's leadership focuses on optimizing the R&D pipeline and enhancing manufacturing capabilities to meet international standards. The President's responsibilities include managing cross-functional teams and driving efficiency across all departments. By championing the company's expansion into new territories, Hyun Howoong strengthens Daewoong's presence in key markets throughout Asia and the United States. This executive's tenure is marked by a dedication to advancing pharmaceutical science and ensuring market access for critical medicines.
Shawn Park - Chief Executive Officer & President
Shawn Park, the Chief Executive Officer & President at Daewoong Pharmaceutical, spearheads the company's global expansion and operational excellence. This leadership position involves directing strategic partnerships and market penetration efforts in diverse international regions, including Asia and the United States. Park's focus is on leveraging Daewoong Pharmaceutical's robust R&D capabilities and cGMP-certified manufacturing to deliver innovative healthcare solutions. The Chief Executive Officer & President ensures seamless integration of new market entries and sustains high standards in product development and commercialization. By overseeing the company's growth trajectory, Shawn Park drives the mission to establish Daewoong Pharmaceutical as a preeminent global healthcare entity. This executive's strategic foresight is crucial for navigating the competitive pharmaceutical landscape and achieving sustained revenue growth.
Namho Kwak - President
Namho Kwak, the President at Daewoong Pharmaceutical, drives the company's operational efficiency and market development initiatives. This executive role focuses on optimizing the supply chain and manufacturing processes, ensuring Daewoong Pharmaceutical's cGMP-qualified facilities consistently meet global quality benchmarks. Kwak's leadership extends to managing key business relationships and fostering collaborations that enhance the company's market presence. The President plays a vital part in executing strategic plans for international growth, particularly in expanding operations across Asia and the United States. By overseeing departmental functions, Namho Kwak ensures that Daewoong Pharmaceutical remains agile and responsive to evolving market demands. This executive's commitment to operational excellence underpins the company's ability to provide comprehensive healthcare solutions worldwide.
Explore Leadership Teams in Manufacturing
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Company Leadership
AD
MB
AR
Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide.
Company Leadership JS
RK
ML
AS
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BT
DG
KK
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership TK
YD
AS
Frequently Asked Questions Regarding Daewoong Pharmaceutical Top Executives and Leadership Team
